| Literature DB >> 34966865 |
Katsuhisa Yamada1, Ken Nagahama2, Yuichiro Abe3, Eihiro Murota2, Shigeto Hiratsuka1, Masahiko Takahata1, Norimasa Iwasaki1.
Abstract
INTRODUCTION: A percutaneous endoscopic transforaminal lumbar interbody fusion (PETLIF) procedure has been previously developed. During postoperative follow-up, in some patients, bone fusion occurred between opened facet joints, despite not having bone grafting in the facet joints. Here, we investigated facet fusion's frequency and tendencies following PETLIF.Entities:
Keywords: facet fusion; lumbar interbody fusion; minimally invasive spinal surgery
Year: 2021 PMID: 34966865 PMCID: PMC8668217 DOI: 10.22603/ssrr.2020-0232
Source DB: PubMed Journal: Spine Surg Relat Res ISSN: 2432-261X
Figure 1.(A) X-ray image of the intermediary position of the lumbar profile. Segmental lordotic angle of the fused lumbar vertebrae was measured. (B) Computed tomography (CT) immediately after percutaneous endoscopic transforaminal lumbar interbody fusion (PETLIF). The maximum interfacet distance was calculated from CT axial images at the upper vertebral endplate level of the fused lower vertebral body.
Figure 2.A 68-year-old female’s computed tomography axial image after L4/5 percutaneous endoscopic transforaminal lumbar interbody fusion (PETLIF) (top row), right parasagittal reconstruction image (bottom row). (A) Prior to surgery, (B) immediately after surgery, (C) 6 months after surgery, and (D) 1 year after surgery. Bone fusion was observed between the opened facet joints, and bilateral facet fusion was observed 1 year after surgery.
Characteristics of Patients in the Facet Fusion and Non-Fusion Groups after PETLIF (n=42).
| Facet fusion
| Facet non-fusion
| p value | ||
|---|---|---|---|---|
| Age, mean±SD (y) | 70.9±9.4 | 68.2±9.5 | 0.19 | |
| Sex | Female | 23 (88.5%) | 13 (81.3%) | 0.41 |
| Male | 3 (11.5%) | 3 (18.8%) | ||
| Diagnosis | ||||
| Degenerative spondylolisthesis | 25 (96.2%) | 14 (87.5%) | 0.40 | |
| Lumbar canal stenosis | 1 (3.8%) | 1 (6.3%) | ||
| Degenerative scoliosis | 0 (0%) | 1 (6.3%) | ||
| Bone mineral density of the total hip, mean±SD (g/cm2) | 0.81±0.14 | 0.78±0.16 | 0.33 | |
| T-score of the total hip, mean±SD | −0.79±1.28 | −1.10±1.28 | 0.23 | |
| Osteoporosis treatment | ||||
| None | 20 (76.9%) | 11 (68.8%) | 0.63 | |
| Bisphosphonate | 2 (7.7%) | 3 (18.8%) | ||
| SERM | 1 (3.8%) | 0 (0%) | ||
| Vitamin D | 3 (11.5%) | 2 (12.5%) | ||
PETLIF: percutaneous endoscopic transforaminal lumbar interbody fusion, SD: standard deviation, SERM: selective estrogen receptor modulator
Radiographic Assessment Between Facet Fusion and Non-Fusion Groups at 1 Year after PETLIF (n=42).
| Facet fusion
| Facet non-fusion
| p value | ||
|---|---|---|---|---|
| Lumbar pseudarthrosis | 0 (0%) | 0 (0%) | 1.00 | |
| Interbody bridging bone | 21 (80.8%) | 11 (68.8%) | 0.57 | |
| Cage subsidence | 4 (15.4%) | 4 (25.0%) | 0.50 | |
| Pedicle screw loosening | 0 (0%) | 1 (6.3%) | 0.33 | |
| Pedicle screw invasion to the facet joint | 3 | 3 | 0.26 | |
| Preoperative % slip on standing X-ray (%) | 20.5±5.7 | 15.9±10.0 | 0.04 | |
| Segmental lordotic angle (º) | ||||
| Prior to surgery | 16.0±6.3 | 11.7±6.3 | 0.02 | |
| Immediately after surgery | 18.5±5.5 | 13.9±5.6 | <0.01 | |
| 1 year after surgery | 17.5±5.8 | 12.9±6.1 | 0.01 | |
| Correction loss (immediately after surgery to 1 year after surgery) | 1.0±1.6 | 0.9±1.2 | 0.42 | |
| Interfacet distance (mm) | ||||
| Prior to surgery | 1.3±0.9 | 1.7±1.1 | 0.12 | |
| Immediately after surgery | 4.5±1.6 | 4.6±1.5 | 0.40 | |
| 1 year after surgery | 3.8±1.4 | 3.7±1.3 | 0.42 | |
| Immediately after surgery to 1 year after surgery | 0.7±0.6 | 0.9±0.9 | 0.18 | |
Data are given as number (%) or mean±standard deviation. PETLIF: percutaneous endoscopic transforaminal lumbar interbody fusion